 Home >

Medical News

Home



Latest Medical News

The Hemophilia A management tool under the guidance of Takeda PK is listed in China

 Time of Update: 2021-01-15

of the drug dose. highlights the importance of individualized preventive therapy. individualized treatment program is based on pharmacodynamics, which enables patients to maintain adequate hemostage-stopping FVIII. levels through optimal dosage
UNITY Anti-Aging Drug Research and Development Made Significant Progress Partner Asasin Pharmaceuticals Received Milestone Payment

 Time of Update: 2021-01-15

BM-962 was selected by UNITY as a compound for research and development of UBX1325, and the cooperation was carried out in accordance with the terms of the agreement between the parties.
TOP 15! Take stock of the highest-paid female CEOs in the biopharmaceutical industry

 Time of Update: 2021-01-15

Executive Officer of the Human Life, Cell Therapy and Laboratories businesses of General Electric Healthcare Life Sciences, Clarient Diagnostics, GenVec and Sequoia Pharmaceuticals. her undergraduate major is microbiology and her master's degree
AstraZenecon has submitted a clinical application for a new generation of oral estrogen-influenced antagonists

 Time of Update: 2021-01-15

AZD9833 belongs to a new generation of oral selective estrogen inhibitors (ER alpha) antagonists and degradation agents (SERDs).
PD-(L)1 Drug More How to Choose?

 Time of Update: 2021-01-15

approved combination chemotherapy first-line treatment of small cell lung cancer Since June 15, 2018 O drug in China was the first approved second-line treatment of advanced non-small cell lung cancer to open the era of tumor tumor immunotherapy, so far
Lingbei: The milestone in the development of new drugs stems from a humanized corporate culture

 Time of Update: 2021-01-15

job of resource arrangements to seize the opportunities in the Chinese market. based on its research and development experience and market base in China, Lingbei will continue to work with the government and local partners to continuously provide
7 drug suspension recalls: Malay acid ammonia chloride tablets, libawelin tablets...

 Time of Update: 2021-01-15

On December 25, Shandong Provincial Drug Administration issued the 9th Issue of Drug Quality Testing Notice 2020 (hereinafter referred to as the "Notice"). circular said that in order to strengthen drug quality supervision and ensure
The phase 3 clinical miss of the phase 3 clinical end point of Opdivo glioblastoma was also missed

 Time of Update: 2021-01-15

). after a routine review of the study by the DMC, Pam was told that based on trial data to date, the study would not be able to meet the primary endpoint of overall survival for patients who did not use baseline corticosteroid hormones. <br
First one-day advanced prostate cancer drug approved by FDA!

 Time of Update: 2021-01-15

previously been given priority review, is the first and only oral gonogen-releasing hormone (GnRH) agent to treat advanced prostate cancer. approval is based on data on the effectiveness and safety of orGOVYX's Phase 3 HERO study of patients
Applications for Phase 3 clinical trials of Deki Pharmaceutical SVd combination therapy for rrMM were accepted by NMPA

 Time of Update: 2021-01-15

output inhibitor (SINE) of its kind and the first and only FDA-approved drug for the treatment of multiple myeloma and diffuse large B-cell lymphoma. Deqi Pharmaceuticals has conducted a Phase 2 registered clinical trial (code-named MARCH

Medical World News

Revealed: The truth about weight gain after quitting smoking

 Time of Update: 2021-01-21

weight gain after quitting smoking was also partly associated with reduced nicotine intake and changes in intestinal bacterigroup composition.
Early screening to prevent sudden death ICD therapy "protects" the heart

 Time of Update: 2021-01-21

attention should also be paid to the treatment of primary morbidity and to avoid related high-risk factors. experts called for: sudden cardiac death needs to be prevented. so-called prevention and control, divided into two aspects. <br
Somaglutide combined cilofexo/firsocostat treatment NASH II with positive results

 Time of Update: 2021-01-21

On November 15th Gilead/Noor and Nord jointly published the results of the Phase II proof-of-concept study. the 5-arm, 24-week phase II clinical study, which included 108 subjects, evaluated noro and Nord's glutatrogin-like peptide-1 (GLP-1
Wanchun "Punablin" International Multi-Center Phase III clinical trials obtained positive results

 Time of Update: 2021-01-21

chemotherapy, severe CIN must be prevented at the source to minimize the adverse clinical consequences associated with CIN. PROCYCTIVE-2 results show that Punablin, with its unique mechanism of action, can quickly act to protect neutral
Grassroots doctors fill out forms, these are mine zones!

 Time of Update: 2021-01-21

a good job in the daily basic public health work. as a primary health worker, the author summarizes some of the places that we need to pay attention to in our work. the core of the epidemic prevention and control article: pre-screening
Biotech meditation

 Time of Update: 2021-01-21

/> the author believes that if investors are willing to give this Group Biotech sufficient time and trust, most of them have the potential to grow into Pharma. Recently, a self-media article entitled "Rivers and lakes are the world of humanity" circulated
Attention! Toothpaste is included in the cosmetics regulatory scope

 Time of Update: 2021-01-21

" regulatory system, fully adapt to the "Cosmetics Supervision and Administration Regulations" for toothpaste management of the new requirements and industrial development needs, regulatory policies from no to there, continuous evolution. 2
The 3rd Golden Pen Award - My Favorite Original Pharmaceutical Writers" Selection Opens

 Time of Update: 2021-01-21

Name) , Contact Email Body Please attach no more than 150 words of personal profile registration consultation: Ms. Xiao 021-33392297 Business/Media Cooperation: Ms. Shen 021-33392534 - The final interpretation of this selection activity belongs to Shanghai Bohua International Exhibition Co., Ltd
Official: Changing the identity of village doctors is treated on an equal level with hospital staff

 Time of Update: 2021-01-21

and other eight departments jointly issued "on the issuance of Wujin District health personnel strong foundation project implementation program (2019-2023)" notice (hereinafter referred to as "Notice"). "Notice" to further strengthen the construction
Dawn at first glance - kras G12C star inhibitor's way forward

 Time of Update: 2021-01-21

grooves can be seen in some cases, and previous studies have shown that there are variants in this area. called the composite binding zone the Switch-II Pocket (S-IIP). Figure 2. Structured relationship study diagram (left); compound 6

Medical Research Articles

China's vaccine research and development work has always been in the world's first square

 Time of Update: 2021-01-14

The State Drug Administration approved the conditional listing of the new coronavirus inactivated vaccine of China National Pharmaceutical Corporation in Beijing on December 30.
Candidate drug modification variant Diabetes treatment drug development research has made important progress

 Time of Update: 2021-01-14

a series of progress in drug development based on FGF21, but it has not solved the problem of FGF21 pharmacological dynamics and stability, which requires frequent administration, which greatly hinders clinical application. in this study
Fourtean drug varieties entered the clinical real-world data application pilot in Boao Lecheng Pre-City District

 Time of Update: 2021-01-14

to the Chinese market, for domestic patients to provide more choices for drug use, but also to enable more Chinese patients to benefit from innovative drugs and medical devices. ," Li said. Gu Gang, director of the Lecheng Advance District
The Guangdong Provincial Center for Disease Control and Prevention has successfully isolated a new strain of coronavirus in South Africa

 Time of Update: 2021-01-13

Pharma.com January 7 According to the official website of the Guangdong Provincial Center for Disease Control and Prevention, on January 6, the Guangdong Provincial Center for Disease Control and Prevention successfully isolated 501Y.V2 South
Official: Newly crowned virus infected persons have been cured and discharged from the hospital within 6 months of refusing to donate blood

 Time of Update: 2021-01-09

Guidelines stipulate that in order to ensure the safety of blood for clinical use, such as blood donation after the emergence of new coronavirus infection-related symptoms, blood donors should promptly return to the blood station; (Complete)
1.1 billion antidepressants have been reviewed in China and the West

 Time of Update: 2021-01-07

hydrochloric acid Lositin intestinal capsule evaluation enterprises gathered 3, respectively, Pelte Pharmaceuticals, Stone Pharmaceuticals Europe, Chinese and Western Pharmaceuticals.
Giniteni is listed as a clinically in urgent need of new drugs from abroad

 Time of Update: 2021-01-07

Center (CDE) clinically in urgent need of foreign new drugs list. understand that the innovative drug's new drug licensing application has been included in the priority review. about 80,000 people in China are diagnosed with leukemia each
The European Union has approved a new crown vaccine for conditional listing

 Time of Update: 2021-01-02

, the European Commission subsequently approved the vaccine in the European Union conditional listing. European Commission President Jean-Claude von der Leyen said in a statement that night that the European Union had decided to grant
Two supplementary applications for iodized kesha alcohol injections from Yangzijiang Pharmaceutical Group were approved

 Time of Update: 2021-01-02

Medicine Network December 21st, December 18th, the official website of the State Drug Administration shows that Yangzijiang Pharmaceutical Group's iodized kesha alcohol injection two supplementary applications were approved for evaluation. <br
Guorui Pharmaceuticals liquorite bhutto morphine injection imitation 3 types of listing applications were accepted

 Time of Update: 2021-01-02

Pharmaceutical network December 21st, before the CDE official website shows that the national pharmaceutical group Guorui Pharmaceuticals' liquorite acid Bhutto morphine injection imitation 3 types of listing applications were accepted. meters

Medical Science News

This toxin is more annoying than diarrhea

 Time of Update: 2021-01-13

coli bacteria to invade the immune system, the key of which is the Zhiga toxin, the study was published in Science-Immunology.
Chinese scholars find "gene therapy" to delay aging

 Time of Update: 2021-01-13

of histogenetic acetyl transferase is the top candidate. The study found that KAT7 expression was increased in human-to-human charged stem cells with physiological and pathological aging. Knocking out the gene can effectively delay cell aging, and over
The biological function of lupus genetic dark matter has been revealed

 Time of Update: 2021-01-13

to the occurrence of the disease, for example, in people with SLE disease, identical twins are far more likely to develop the disease than identical twins. Therefore, the study of the genomic function that determines genetics will help to reveal
It is revealed that the DNA of hepatitis B virus and human genome are landscaped

 Time of Update: 2021-01-12

The study describes the characteristics of the interaction between HBV DNA and the host genome in the form of HBV DNA and integrated forms, providing new potential targets for the treatment of HBV infection and related diseases.
Steady magnetic fields lower blood sugar in diabetic mice

 Time of Update: 2021-01-12

"Hold your mouth and open your legs" is a six-word maxim for diabetics, and new research suggests that "magnetic field exposure" could be a new boon for diabetics. in a paper published online January 6 in Innovation, Zhang Xin
Brain "code" marks where you go

 Time of Update: 2021-01-12

study has shown that low-frequency brain waves produced by neurons in the inner temporal lobe can help rodents track their location as they navigate new places.
Scientists combed for studies on the correlation between lysic acid and inflammatory factors

 Time of Update: 2021-01-12

diseases. According to an existing Meta analysis, the Mediterranean diet and the olive oil in it reduced C-reactive protein and interlebin-6 levels. Lyoic acid is the main fatty acid component of Mediterranean diet patterns and olive oil (more than 70
Treating autoimmune diseases has the "one-of-a-world key".

 Time of Update: 2021-01-12

, chemistry, biology and other interdisciplinary disciplines, set up a controlled, universal CAR-T platform method, for safer and more effective CAR-T applications to provide a new technical reserve, and for autoimmune diseases and tumor precision
Expect pulmonary hypertension patients to "take fewer detours"

 Time of Update: 2021-01-12

patients usually need to transfer multiple departments, multiple places to be finally diagnosed. and even after diagnosis, the treatment and follow-up management of PH patients is not optimistic. For example, without a right heart
A protein causes breast cancer to worsen faster

 Time of Update: 2021-01-06

University of South Australia said in a statement that its researchers had found that a protein that makes breast cancer worse could lead to new treatments for breast cancer.

Medicines Company News

Kingsley founder Zhang Fangliang was formally arrested and shares fell more than 14% as CAR-T therapy continued to burn

 Time of Update: 2021-01-17

cell therapy products are expected to go on sale next year with continued research and development investment leading to the loss-making Big Kingsley subsidiary Legendary Bio specializes in CAR-T cell immunotherapy, which successfully landed on NASDAQ earlier this year.
Stone pharmaceutical revenue in the first three quarters of nearly 20 billion research and development investment increased by more than 50% YoY

 Time of Update: 2021-01-17

period, anti-tumor products recorded sales revenue of RMB4,717 million, an increase of 35.4% YoY.
Xinda Bio announced that Adamo monoantigen injections have been approved for new adaptations in China

 Time of Update: 2021-01-17

, fatality rate, seriously affecting the quality of life of children. early positive treatment can improve outcomes and prevent potential complications. Since its launch, the original drug Adamo monoantigen has been approved worldwide
PD-1/PD-L1 Re-entered Health Insurance China's innovative pharmaceutical company research and development and commercialization capabilities big PK

 Time of Update: 2021-01-17

as the winner of the 2019 PD-1/PD-L1 health care negotiations, Cinda Bio is the only pharmaceutical company in China with a second-line layout of squamous cancer in the field of non-small cell lung cancer.
Innovative drug Xinrui Hui Pharmaceuticals announced the completion of the B-plus round of financing

 Time of Update: 2021-01-17

the company has completed two rounds of financing, including Taifu Capital, Gaoli Capital, Obo Capital, Boyuan Capital, Lilly Asia Fund, Power Capital and Mitsui International Investment.
Lilly has teamed up with Precision for gene therapy for Duchy's muscular dystrophy

 Time of Update: 2021-01-17

not currently have an effective treatment, creating drugs with transformational potential by working closely with the Precision scientific team and using their platform to develop and deliver drugs that target untreated genetic diseases. , of course
The GV1001 drug trial yielded more positive results

 Time of Update: 2021-01-17

, the company has announced that the GV1001 has good tolerance and safety, and achieved the main endpoint by making significant improvements in the SIB score.
Mercadon's $425 million cash acquisition of Anko immunity expands the COVID-19 product pipeline

 Time of Update: 2021-01-17

Immunity recently announced positive top-line results in a clinical Phase 3 study evaluating the clinical phase efficacy of patients treated with the leading therapeutic candidate CD24Fc in patients with severe and critical COVID-19.
SEL-212 Enters Phase III Clinical Trials Sansheng Pharmaceuticals receives a milestone payment of $4 million

 Time of Update: 2021-01-17

On November 23rd Sansheng Pharmaceuticals announced that its partner, Selecta, had conducted phase III clinical trials of the combination therapy SEL-212 for chronic recurring gyration on behalf of Sobi™ and had paid a milestone payment of $4
AstraZeneta has announced that its new crown vaccine has reached the primary efficacy of preventing COVID-19

 Time of Update: 2021-01-17

independent data security monitoring committee determined that the analysis reached its primary endpoint and showed the protection of COVID-19 that occurred 14 days or more after two doses of the vaccine.

Hot Products

3-(4-Phenoxyphenyl)-1H- pyrazole and [3,4- d] pyrimidine-4-amine 98% white powder

CAS No.: 330786-24-8

Pharmacy Grade

$700-900/KG FOB

(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid

CAS No.: 159622-10-3

$100/KG FOB

(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid

CAS No.: 159622-10-3

$100/KG FOB

Hot Tags

1 propanamine(4127)

2 2 dimethylbutane(2475)

abilify medication(2136)

achondroplasia treatment(1535)

Hot Posts

Trending Keywords

a storage box

contact media and communications

cardboard boxes

c core company details

box cardboard box

davidson companies careers

grace general hospital careers

australian catalog company

c battery contacts

organic mirepoix

Chemical Exhibitions

The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.